Anbc, Inc.
$0.00$0.00 (0.0%)
Anbc, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.0% below the high.
OTC · NXGB · USD
Stock price
Quote as of Oct 30, 2026, 02:49 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NxGen Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Operating under the brand name LeafyWell, NxGen Brands Inc. is dedicated to the production, distribution, and promotion of a wide array of cannabidiol (CBD) supplements. The company's product line features various CBD and hemp-derived goods, including edible gummies, oils, vaporizer liquids, pet-specific treats, and other offerings. Its operations are headquartered in Davie, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:07 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Anbc, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.0% below the high.
$0.00$0.00 (0.0%)
ForU Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (+100.0%)
Genex Pharmaceutical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
Cotinga Pharmaceuticals Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Urologix, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.21% below the high.
$0.00$0.00 (0.0%)
CanaQuest Medical Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Tibet Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.